Join our Community
Support ToI and remove all ads
Learn more
×

pharmaceuticals

Prof. Alexander Binshtok, left, from the Hebrew University’s Faculty of Medicine and Center for Brain Sciences (Courtesy/Maxim Dinshtein) and Prof. Avi Priel from its School of Pharmacy (Courtesy/Avi Priel)
June 11, 2025, 3:28 pm
Israeli study finds acetaminophen drug works by first blocking pain in nerves
In breakthrough, Hebrew University researchers say painkiller, in use since the 1950s, acts like a local anesthetic; research could lead to better pain management
By Diana Bletter
An Israeli flag flies outside a Teva Pharmaceutical Industries building on Dec. 14, 2017, in Neot Hovav, Israel. (AP/Tsafrir Abayov, File)
October 12, 2024, 6:47 pm
Israel’s Teva agrees to pay $450m in settlements in US kickback, price-fixing cases
US Department of Justice announces resolutions to allegations of wrongdoing, which pharmaceutical company continues to deny, to be paid over 6 years
By Reuters
Illustrative. Digital health technology. (chombosan; iStock by Getty Images)
September 11, 2023, 10:02 pm
Israeli life sciences firms’ capital-raising slows 40% in first half of 2023
Local life sciences companies turn to US stock markets for funding; private foreign investors’ activity more than halves, data by Israel Advanced Technology Industries (IATI) shows
By Sharon Wrobel
Industry leaders, scientists, engineers, physicians, and investors from over 45 countries at Biomed Israel 2023 conference, Tel Aviv, May 16, 2023. (Alexander Elman)
May 17, 2023, 10:47 pm
At Biomed Israel conference, medical start-ups discuss challenges in reaching success
Companies dealing in life sciences and technology face tougher times ahead due to global economic uncertainty and political crisis at home
By Renee Ghert-Zand
FILE - In this Aug. 14, 2018 file photo, a doctor looks at PET brain scans in Phoenix (AP Photo/Matt York, File)
November 30, 2022, 12:08 pm
In first, new Alzheimer’s drug modestly slows progress of disease, researchers say
US, Japanese drugmakers announce results of full study, but remains unclear how much of a difference it may make to lives of those affected by the condition
By LAURAN NEERGAARD
Illustrative image: A pharmacist dispensing medicine (MJ_Prototype via iStock by Getty Images)
November 8, 2022, 1:59 pm
Pharmacists appeal to government to intervene amid shortages of Ritalin, other drugs
Drugstores unable to honor prescriptions for certain Ritalin dosages, some anxiety medications, and some heart medications, say they are raising a ‘red flag’
By Nathan Jeffay
OMEC.AI co-founders Ori Shachar, left, and Amir Harel, right. (Elad Malka)
September 28, 2022, 2:08 pm
Israeli innovation lab backed by pharmaceutical, biotech giants mints 1st AI startup
AION Labs, a Rehovot-based consortium formed by Pfizer, Merck, AstraZeneca, Teva and others, sets up company that will help drug firms improve chances of success in clinical trials
By Ricky Ben-David
A woman walks in front of Pfizer's headquarters in Manhattan, November 2020. (Massimo Giachetti via iStock by Getty Images)
September 20, 2022, 3:00 pm
Pfizer backs Israel’s CytoReason, inks new research deal for AI drug development
US pharmaceutical giant to make $20m equity investment, part of larger agreement to license tech and collaborate on R&D
By Ricky Ben-David
German pharmaceutical giant Bayer's logo at the company's Berlin headquarters, May 2016. (brunocoelhopt via iStock by Getty Images)
June 29, 2022, 9:30 pm
Pharma giant Bayer to set up cybersecurity center in Israel
German multinational to operate large local cyber unit tasked with creating partnerships with local tech ecosystem
By Ricky Ben-David
Illustrative image: an elderly woman in hospital (LightFieldStudios via iStock by Getty Images)
June 29, 2022, 6:07 pm
Israeli tech works to avert hospitalizations by flagging problems with clashing meds
Undetected problems with treatment regimens land many elderly patients in hospital; artificial intelligence system that sounds an alarm is built in Tel Aviv, deployed by Leumit HMO
By Nathan Jeffay
The Pfizer building on East 42nd Street in New York City. (ChainGangPictures via iStock by Getty Images)
February 10, 2022, 5:15 pm
Pfizer extends cooperation deal with Israeli AI drug development firm CytoReason
Tel Aviv-based startup uses machine learning to build computational models of human diseases to speed up treatment discoveries
By Ricky Ben-David
Illustration of the liver in a woman's body (Tharakorn via iStock by Getty Images)
November 3, 2021, 6:00 pm
Small trial of Israeli drug shows promise for treating fatty liver disease
Fibrosis progressed less than average amount in 15 of the 16 patients enrolled; half of the sample saw their fibrosis go back a stage
By Nathan Jeffay
An illustrative photo of a scientist in protective gear working in a lab. (gorodenkoff via iStock by Getty Images)
September 30, 2021, 1:45 pm
Japanese pharmaceutical firm taps Israel’s CytoReason for AI drug development
Tel Aviv-based startup uses machine learning to build computational models of human immune system and diseases to speed up treatments
By Ricky Ben-David
Former Mossad chief Tamir Pardo. (Courtesy)
September 1, 2021, 7:00 pm
Ex-Mossad chief joins pharma company commercializing Israeli COVID jab
Tamir Pardo signs on as board member of NRx pharmaceuticals, which is completing trials for BriLife vaccine in Georgia, Ukraine
By Ricky Ben-David
Arthur M. Sackler in his office in this undated photo. (Wikimedia commons/ CC BY-SA 2.0/ Smithsonian Freer and Sackler Galleries)
July 5, 2021, 4:19 am
How the Sackler family built a pharma dynasty and fueled an American calamity
In ‘Empire of Pain,’ Patrick Radden Keefe details the humble Jewish immigrant roots of Purdue Pharmaceuticals, and how it is evading justice despite being behind the opioid crisis
By Rich Tenorio
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.